×

img Acces sibility Controls

Technologies Banner

All Technologies

Synthesis of Cetyl Myristoleate (CMO) Isomers for the Treatment of Osteoarthritis and Other Joint Inflammatory Diseases

Implementing Organization

Indian Institute of Chemical Technology (IICT)

Project Overview

Cetyl myristoleate (CMO) is the common name for hexadecyl cis-9- myristoleate. CMO is well known for its anti-arthritis properties. The main component of CMO is cis-9 myristoleic acid, and is being isolated from selective natural sources along with other fatty acids. CMO is being sold in the market for the treatment of different forms of arthritis, osteoarthritis, as well as many other forms of diseases.
Funding Organization
Funding Organization

Quick Information
Area of Research
Medical Sciences
Focus Area
Treatment of Osteoarthritis
Status
1
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :01
Grant :00
arrowtop